Vaneast Pictures founded by Danielle Gasher has acquired the international sales rights for the upcoming horror thriller, The Cure, starring David Dastmalchian (Late Night with the Devil), Ashley Greene (Twilight), Sydney Taylor (Marked Men) and Samantha Cochran in her feature film debut. The Cure is directed by Nancy Leopardi, whose previous credits include Nanny Cam and Lethal Seduction.
Ally Braun, a 16-year-old adopted girl with a mysterious illness, discovers her biotech billionaire parents are harvesting her blood for sinister reasons. As the twisted experiments escalate, she must fight to escape before she’s drained of everything that makes her human.
“The Cure is a gripping and unnerving addition to the Vaneast slate. David Dastmalchian and Ashley Greene are magnetic in roles that crawl under your skin. We’re excited to screen the film for buyers at TIFF,” said Danielle Gasher, Vaneast Pictures.
“The Cure” is a crowd pleasing thriller based on the modern billionaire’s obsession with extending their lives. It is a look through the terrified eyes of an innocent girl whose body is not considered her own and is exploited for the benefit of the Uber-wealthy. The story exists in the great tradition of horror and sci-fi films that are inspired by futuristic advances in science and technology. Like the filmmakers of Ex-Machina, A.I., and Videodrome, I believe we are on the cusp of a bio-tech revolution and the big question is – who will benefit? I’m so excited to be working with Danielle Gasher from Vaneast Pictures and Jay Cohen from The Gersh Agency for sales on this film. Their guidance and support have been key to getting this seen by the people who appreciate the elevated horror/thriller audience,” said Director Nancy Leopardi.
The Cure is produced by Nancy Leopardi, John Ierardi and Bo Youngblood. Danielle Gasher will also serve as an executive producer on the film. Gersh is handling domestic sales for the film.